Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 50 u - muscle relaxants

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 100 u - muscle relaxants

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 50unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 100unit

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.8 ng 100 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.2 - 0.4 ng 50 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

Ireland - English - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neurotoxin type a (150kd), free of complexing proteins - powder for solution for injection - 100 unit(s) - botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neurotoxin type a (150kd), free of complexing proteins - powder for solution for injection - 50 unit(s) - botulinum toxin

Singapore - English - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins - injection, powder, for solution - 100 ld50 units - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins 100 ld50 units

Singapore - English - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins - injection, powder, for solution - 50 ld50 units - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins 50 ld50 units